ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Turnstone Biologics Corporation

Turnstone Biologics Corporation (TSBX)

0.4135
0.0235
(6.03%)
Closed February 17 4:00PM
0.4135
0.00
(0.00%)
After Hours: 6:01PM
Advanced chart

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.4135
Bid
0.381
Ask
0.4775
Volume
47,880
0.3825 Day's Range 0.4136
0.365 52 Week Range 5.75
Market Cap
Previous Close
0.39
Open
0.3825
Last Trade
5
@
0.4171
Last Trade Time
Financial Volume
$ 19,123
VWAP
0.3994
Average Volume (3m)
203,102
Shares Outstanding
23,128,454
Dividend Yield
-
PE Ratio
-0.17
Earnings Per Share (EPS)
-2.39
Revenue
19.31M
Net Profit
-55.2M

About Turnstone Biologics Corporation

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across mu... Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient's tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
La Jolla, California, USA
Founded
-
Turnstone Biologics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSBX. The last closing price for Turnstone Biologics was $0.39. Over the last year, Turnstone Biologics shares have traded in a share price range of $ 0.365 to $ 5.75.

Turnstone Biologics currently has 23,128,454 shares outstanding. The market capitalization of Turnstone Biologics is $9.02 million. Turnstone Biologics has a price to earnings ratio (PE ratio) of -0.17.

TSBX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0504-10.86441043330.46390.47330.3653510620.41013098CS
4-0.0356-7.926965041190.44910.53190.3653541540.44778474CS
12-0.0565-12.02127659570.470.62320.3652031020.47597681CS
26-1.8465-81.7035398232.262.26140.3653147990.63503611CS
52-1.7865-81.20454545452.25.750.3652301411.37908095CS
156-10.9865-96.372807017511.413.20.3651827401.99238702CS
260-10.9865-96.372807017511.413.20.3651827401.99238702CS

TSBX - Frequently Asked Questions (FAQ)

What is the current Turnstone Biologics share price?
The current share price of Turnstone Biologics is $ 0.4135
How many Turnstone Biologics shares are in issue?
Turnstone Biologics has 23,128,454 shares in issue
What is the market cap of Turnstone Biologics?
The market capitalisation of Turnstone Biologics is USD 9.02M
What is the 1 year trading range for Turnstone Biologics share price?
Turnstone Biologics has traded in the range of $ 0.365 to $ 5.75 during the past year
What is the PE ratio of Turnstone Biologics?
The price to earnings ratio of Turnstone Biologics is -0.17
What is the cash to sales ratio of Turnstone Biologics?
The cash to sales ratio of Turnstone Biologics is 0.49
What is the reporting currency for Turnstone Biologics?
Turnstone Biologics reports financial results in USD
What is the latest annual turnover for Turnstone Biologics?
The latest annual turnover of Turnstone Biologics is USD 19.31M
What is the latest annual profit for Turnstone Biologics?
The latest annual profit of Turnstone Biologics is USD -55.2M
What is the registered address of Turnstone Biologics?
The registered address for Turnstone Biologics is 9310 ATHENA CIRCLE, SUITE 300, LA JOLLA, CALIFORNIA, 92037
Which industry sector does Turnstone Biologics operate in?
Turnstone Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
$ 138.85
(2.63%)
189.56M

TSBX Financials

Financials

TSBX Discussion

View Posts
jondoeuk jondoeuk 4 months ago
60% RIF (cash into 2026) https://www.oncologypipeline.com/apexonco/no-easy-ride-turnstone
👍️0
Stock Shakers Stock Shakers 6 months ago
https://www.tipranks.com/stocks/tsbx/forecast
👍️0
Monksdream Monksdream 6 months ago
TSBX new 52+week low
👍️0
jondoeuk jondoeuk 6 months ago
I assume (rightly or wrongly) it is down as they were supposed to have shared data on ~20-30 patients. There was also no conference call and they cut two indications (I agree with melanoma). Data shows promise, but you have to show the market more than that.

https://finance.yahoo.com/news/turnstone-biologics-corp-reports-positive-200100662.html
👍️0
Monksdream Monksdream 7 months ago
TSBX under $3
👍️0
Monksdream Monksdream 7 months ago
TSBX under $3
👍️0
stock1ace1 stock1ace1 8 months ago
$3.02
👍️0
stock1ace1 stock1ace1 8 months ago
$2.94 buys coming in
👍️0
stock1ace1 stock1ace1 8 months ago
Tsbx -> We remain on track and plan to provide a TIDAL-01 clinical update mid-year in connection with our next quarterly financial results.”
👍️0
stock1ace1 stock1ace1 8 months ago
$3.00s (200ma break) #Bullish
👍️0
stock1ace1 stock1ace1 8 months ago
Tsbx $2.99 Pending data look at chart -> https://schrts.co/JiDydKgr
👍️0
Monksdream Monksdream 9 months ago
TSBX under $3
👍️0
jondoeuk jondoeuk 9 months ago
CEO saying data in July-August.
👍️0
Monksdream Monksdream 10 months ago
TSBX under $3
👍️0
Laster Laster 10 months ago
Nice biotech company. Looks like it wants to break out past $3.50.
I think it has a lot more to run,
JMO.
👍️0
TrendTrade2016 TrendTrade2016 12 months ago
TSBX....here we go...monster bio
👍️0
TrendTrade2016 TrendTrade2016 12 months ago
TSBX...MONSTER BIO BEAST IS READY TO BLOW UP
👍️0
jondoeuk jondoeuk 1 year ago
What was?
👍️0
Awl416 Awl416 1 year ago
That was quick
👍️0
jondoeuk jondoeuk 1 year ago
https://twitter.com/jitcancer/status/1710328085151727650
👍️0
jondoeuk jondoeuk 1 year ago
Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html
👍️0